The Global Monoclonal Antibody Partnering Terms and Agreements 2016 to 2023 report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. …
Major players in the chemotherapy market are GlaxoSmithKline PLC, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi S A, Celgene Corporation, Bristol-…
Major players in the veterinary oncology market are PetCure Oncology, Zoetis Inc, Karyopharm Therapeutics Inc, Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International Gmb…
Asia-Pacific (APAC) Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 …
BRIC Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “BRIC …
EU5 Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “EU5 Pr…
North America Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summa…
Major players in the targeted therapy market are Amgen Inc., GlaxoSmithKline plc, Sanofi, Merck & Co., Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca, Bristol Myers Squibb, Takeda Pharmaceu…
Major players in the anti-cancer mabs market are Amgen Inc., Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genmab AS, GlaxoSmithKline PLC., Johnson & Johnson, Novarti…
United States of America (USA) Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Foreca…
United Kingdom (UK) Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 …
France Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Fra…
Germany Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Ge…
Italy Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Ital…
Spain Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Spai…
Russia Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Rus…
South Korea Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary…
China Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Chin…
India Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Indi…
Japan Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Japa…
Australia Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “…
Mexico Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Mex…
Brazil Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Bra…
Canada Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 Summary “Can…
The Global Cancer Vaccine Partnering Terms and Agreements 2010-2023 report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading…
The Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2016-2023 report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered in…
Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules hav…
BiSpecific mAbS Global Market Opportunities And Strategies To 2032 provides the strategists; marketers and senior management with the critical information they need to assess the global bi-specific mA…
Major players in the urothelial cancer drugs market are F Hoffmann La Roche AG, The Bristol-Myers Squibb Company, Merck & Co Inc., Pfizer Inc., Genentech Inc., GSK PLC., UroGen Pharma Inc., Johnson & …
Major companies in the biologics market include AbbVie, Johnson & Johnson, Amgen, Sanofi S.A, F. Hoffmann-La Roche Ltd., GlaxosmithKline, Novartis AG, Pfizer Inc., Teva Pharmaceuticals and CSL. The g…
